GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Redx Pharma PLC (LSE:REDX) » Definitions » Price-to-Free-Cash-Flow

Redx Pharma (LSE:REDX) Price-to-Free-Cash-Flow : N/A (As of Jun. 14, 2024)


View and export this data going back to 2015. Start your Free Trial

What is Redx Pharma Price-to-Free-Cash-Flow?

As of today (2024-06-14), Redx Pharma's share price is £0.15. Redx Pharma's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Sep. 2023 was £-0.10. Hence, Redx Pharma's Price-to-Free-Cash-Flow Ratio for today is N/A.

The historical rank and industry rank for Redx Pharma's Price-to-Free-Cash-Flow or its related term are showing as below:

During the past 12 years, Redx Pharma's highest Price-to-Free-Cash-Flow Ratio was 505.00. The lowest was 0.33. And the median was 126.82.

LSE:REDX's Price-to-Free-Cash-Flow is not ranked *
in the Biotechnology industry.
Industry Median: 31.085
* Ranked among companies with meaningful Price-to-Free-Cash-Flow only.

Redx Pharma's Free Cash Flow per Share for the six months ended in Sep. 2023 was £-0.05. Its Free Cash Flow per Share for the trailing twelve months (TTM) ended in was £-0.10.

During the past 12 years, Redx Pharma's highest 3-Year average Free Cash Flow per Share Growth Rate was 39.20% per year. The lowest was -74.70% per year. And the median was -4.80% per year.


Redx Pharma Price-to-Free-Cash-Flow Historical Data

The historical data trend for Redx Pharma's Price-to-Free-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Redx Pharma Price-to-Free-Cash-Flow Chart

Redx Pharma Annual Data
Trend Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
Price-to-Free-Cash-Flow
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 282.36 - - -

Redx Pharma Semi-Annual Data
Mar14 Sep14 Mar15 Sep15 Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23
Price-to-Free-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Redx Pharma's Price-to-Free-Cash-Flow

For the Biotechnology subindustry, Redx Pharma's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Redx Pharma's Price-to-Free-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Redx Pharma's Price-to-Free-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Redx Pharma's Price-to-Free-Cash-Flow falls into.



Redx Pharma Price-to-Free-Cash-Flow Calculation

Redx Pharma's Price-to-Free-Cash-Flow ratio for today is calculated as

Price-to-Free-Cash-Flow Ratio=Share Price/ Free Cash Flow per Share (TTM)
=0.15/-0.104
=N/A

Redx Pharma's Share Price of today is £0.15.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Redx Pharma's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Sep. 2023 was £-0.10.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

Price-to-Free-Cash-Flow Ratio=Market Cap/Free Cash Flow

Redx Pharma  (LSE:REDX) Price-to-Free-Cash-Flow Explanation

Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.

In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.


Be Aware

In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.


Redx Pharma Price-to-Free-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Redx Pharma's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Redx Pharma (LSE:REDX) Business Description

Traded in Other Exchanges
N/A
Address
Block 33, Mereside, Alderley Park, Macclesfield, GBR, SK10 4TG
Redx Pharma PLC is a United Kingdom-based biotechnology company focused on the development of novel precision medicines that have the potential to transform treatment in oncology and fibrotic diseases. Its product pipeline under development includes Porcupine Inhibitor, ROCK2 Selective Inhibitor, GI-targeted ROCK inhibitor, Pan-RAF Inhibitor, and others. The firm operates geographically in UK and Ireland. Revenue is generated from; Scientific programmes and research collaboration, Research collaboration and Research and preclinical development services. Redx is a clinical-stage biotechnology company focused on the discovery & development of novel, small-molecule, targeted medicines for the treatment of cancer and fibrotic disease and the emerging area of cancer-associated fibrosis.

Redx Pharma (LSE:REDX) Headlines

No Headlines